Osilodrostat can provide control of urinary free cortisol for over 2.5 years in patients with cushing's disease: Results from an extension to the linc-2 study

Authors
Category Primary study
JournalEndocrine Reviews
Year 2017
This article has no abstract
Epistemonikos ID: 6c94dcbf5fea4d05fe55c4a56a71c140a9994fdd
First added on: Feb 08, 2025